Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate in Refractory Partial Epilepsy
NCT00236873Phase 2Completed
- Sponsor
- Johnson & Johnson
- Start
- Oct 1989
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of topiramate in epilepsy, sponsored by Johnson & Johnson. Started Oct 1989; status: completed.
02
Drugs
topiramate
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT00236873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00236873.